SEC Filing Details

Document Details

Form
Filing Date
Jan 4, 2021
Document Date
Jan 1, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.
Filer
JIMENEZ FREDDY A.

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline